Antitumor activities on HL-60 human leukemia cell line, molecular docking, and quantum-chemical calculations of some sulfonamide-benzoxazoles

References

• Abdelgawad MA, Abdellatif KRA, Ahmed OM. 2014. Design, synthesis and anticancer screening of novel pyrazole derivatives linking to benzimidazole, benzoxazole and benzothiazole. Med Chem. S1:001. doi:10.4172/2161-0444.S1-001.
   Google Scholar
• Akbal O, Erdal E, Vural T, Kavaz D, Denkbaş EB. 2016. Comparison of protein- and polysaccharidebased nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line. Artif Cells Nanomed Biotechnol.17:1–11. doi:10.3109/21691401.2016.1170694.
   Google Scholar
• Akbay A, Oren I, Temiz-Arpaci O, Aki-Sener E, Yalcin I. 2003. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. Arzneim Forsch. 53:266–271.
   PubMed Web of Science ®Google Scholar
• Akurathi V, Dubois L, Lieuwes NG, Chitneni SK, Cleynhens BJ, Vullo D, et al. 2010. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia. Nucl Med Biol. 37:557–564.
   PubMed Web of Science ®Google Scholar
• Baldwin EL, Osheroff N. 2005. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents. 5:363–372.
   PubMedGoogle Scholar
• Becke AD. 1993. Density‐functional thermochemistry. III. The role of exact exchange. J Chem Phys. 98:5648–5652.
   Web of Science ®Google Scholar
• Caleta I, Kralj M, Marjanovic M, Bertosa B, Tomic S, Pavlovic G, et al. 2009. Novel cyano- and amidinobenzothiazole derivatives: synthesis, antitumor evaluation, and X-ray and quantitative structure-activity relationship (QSAR) analysis. J Med Chem. 52:1744–1756.
   PubMed Web of Science ®Google Scholar
• Chai CD, Head-Gordon M. 2008. Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys Chem Chem Phys. 10:6615–6620.
   PubMed Web of Science ®Google Scholar
• Chandak N, Bhardwaj JK, Sharma R, Sharma PK. 2013. Inhibitors of apoptosis in testicular germ cells: synthesis and biological evaluation of some novel IBTs bearing sulfonamide moiety. Eur J Med Chem. 59:203–208.
   PubMed Web of Science ®Google Scholar
• Crespo R, de Bravo MG, Colinas PA, Bravo RD. 2010. In vitro antitumor activity of N-glycosyl sulfonamides. Bioorg Med Chem Lett. 20:6469–6471.
   PubMed Web of Science ®Google Scholar
• Discovery Studio 3.5, Accelrys Inc. 2012.
   Google Scholar
• El-Hady HA, Abubshait SA. 2015. Synthesis of imidazolinone and benzoxazole derivatives, and evaluation of their anticancer activity. Res Chem Intermediat. 41:1833–1841.
   Web of Science ®Google Scholar
• Ertan T, Yildiz I, Tekiner-Gulbas B, Bolelli K, Temiz-Arpaci O, Ozkan S, et al. 2009. Synthesis, biological evaluation and 2d-QSAR analysis of benzoxazoles as antimicrobial agents. Eur J Med Chem. 44:501–510.
   PubMed Web of Science ®Google Scholar
• Ertan-Bolelli T, Musdal Y, Bolelli K, Yilmaz S, Aksoy Y, Yildiz I, Aki-Yalcin E, Yalcin I. 2014. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features. ChemMedChem. 9:984–992.
   PubMed Web of Science ®Google Scholar
• Ertan-Bolelli T, Yildiz I, Ozgen-Ozgacar S. 2016. Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives. Med Chem Res. 25:553–567.
   Web of Science ®Google Scholar
• Fleming I. 1976. Frontier Orbitals and Organic Chemical Reactions. Trowbridge, Wiltshire: Wiley Redwood Books, pp. 1.
   Google Scholar
• Gautam MK. Sonal, Sharma NK, Priyanka, Jha KK. 2012. Pharmacological profile and pharmaceutical importance of substituted benzoxazoles: a comprehensive review. Int J ChemTech Res. 4:640–650.
   Google Scholar
• Gaussian 09, Revision D.01, Frisch, Trucks GV, Schlegel HB, Scuseria GE, et al. 2009. Wallingford, CT: Gaussian Inc.
   Google Scholar
• Jagani H, Kasinathan N, Meka SR, Josyula VR. 2016. Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: a mini review. Artif Cells Nanomed Biotechnol. 44:1212–1221.
   PubMed Web of Science ®Google Scholar
• Kamal A, Reddy KS, Khan MN, Shetti RV, Ramaiah MJ, Pushpavalli SN, et al. 2010. Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem. 18:4747–4761.
   PubMed Web of Science ®Google Scholar
• Kim JSQ, Gatto B, Yu C, Liu A, Liu LF, La Voie EJ. 1996. Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons. Bioorg Med Chem. 6:163–172.
   Web of Science ®Google Scholar
• Klimesová V, Kocí J, Waisser K, Kaustová J, Möllmann U. 2009. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents. Eur J Med Chem. 44:2286–2293.
   PubMed Web of Science ®Google Scholar
• Krishna R, Mayer LD. 2000. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci. 11:265–283.
   PubMed Web of Science ®Google Scholar
• Lage H, Aki-Sener E, Yalcin I. 2006. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs. Int J Cancer. 119:213–220.
   PubMed Web of Science ®Google Scholar
• Lee C, Yang W, Parr RG. 1988. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B Condens Matter. 37:785–789.
   PubMed Web of Science ®Google Scholar
• Mathew N, Kalyanasundaram M, Balaraman K. 2006. Glutathione-S-transferase inhibitors. Expert Opin Ther Pat. 16:431–444.
   Web of Science ®Google Scholar
• Mossmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 65:55–63.
   PubMed Web of Science ®Google Scholar
• Nitiss JL. 2009. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 9:338–350.
   PubMed Web of Science ®Google Scholar
• Oksuzoglu E, Tekiner-Gulbas B, Alper S, Temiz-Arpaci O, Ertan T, Yildiz I, et al. 2008. Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors. J Enzyme Inhib Med Chem. 23:37–42.
   PubMed Web of Science ®Google Scholar
• Omar MA, Shaker YM, Galal SA, Ali MM, Kerwin SM, Li J, et al. 2012. Synthesis and docking studies of novel antitumor benzimidazoles. Bioorg Med Chem. 20:6989–7001.
   PubMed Web of Science ®Google Scholar
• Oren I, Temiz O, Yalcin I, Sener E, Akin A, Ucarturk N. 1997. Synthesis and microbiological activity of 5 (or 6)-methyl-2- substituted benzoxazole and benzimidazole derivatives. Arzneim Forsch/Drug Res. 47:1393–1397.
   PubMed Web of Science ®Google Scholar
• Oren I, Temiz O, Yalcin I, Sener E, Altanlar N. 1998. Synthesis and antimicrobial activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivatives. Eur J Pharm Sci. 7:153–160.
   Web of Science ®Google Scholar
• Owa T, Yoshino H, Okauchi T, Yoshimatsu K, Ozawa Y, Sugi NH, et al. 1999. Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J Med Chem. 42:3789–3799.
   PubMed Web of Science ®Google Scholar
• Padalkar VS, Borse BN, Gupta VD, Phatangare KR, Patil VS, Umape PG, et al. 2012. Synthesis and antimicrobial activity of novel 2-substituted benzimidazole, benzoxazole and benzothiazole derivatives. Arab J Chem. doi:10.1016/j.arabjc.2011.12.006.
   Web of Science ®Google Scholar
• Pinar A, Yurdakul P, Yildiz-Oren I, Temiz-Arpaci O, Acan NL, AkiSener E, Yalcin I. 2004. Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem Biophys Res Commun. 317:670–674.
   PubMed Web of Science ®Google Scholar
• Plemper RK, Erlandson KJ, Lakdawala AS, Prussia A, Boonsombat J, Aki-Sener E, et al. 2004. A target site for template-based design of measles virus entry inhibitors. Proc Natl Acad Sci USA. 101:5628–5633.
   PubMed Web of Science ®Google Scholar
• Rida SM, Ashour FA, El-Hawash S, El-Semary M, Badr MH, Shalaby MA. 2005. Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents. Eur J Med Chem. 40:949–959.
   PubMed Web of Science ®Google Scholar
• Sato S, Kajiura T, Noguchi M, Takehana K, Kobayashi T, Tsuji T. 2001. AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiot. 54:102–104.
   PubMed Web of Science ®Google Scholar
• Satyendra RV, Vishnumurthy KA, Vagdevi HM, Rajesh KP, Manjunatha H, Shruthi A. 2011. Synthesis, in vitro antioxidant, anthelmintic and molecular docking studies of novel dichloro substituted benzoxazole-triazolo-thione derivatives. Eur J Med Chem. 46:3078–3084.
   PubMed Web of Science ®Google Scholar
• Schisselbauer JC, Silber R, Papadopoulos E, Abrains K, LaCreta FP, Tew KD. 1990. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res. 50:3562–3568.
   PubMed Web of Science ®Google Scholar
• Seenaiah D, Ramachandra Reddy P, Mallikarjuna Reddy G, Padmaja A, Padmavathi V, Siva Krishna N. 2014. Synthesis, antimicrobial and cytotoxic activities of pyrimidinyl benzoxazole, benzothiazole and benzimidazole. Eur J Med Chem. 77:1–7.
   PubMed Web of Science ®Google Scholar
• Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I, et al. 1996. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem. 39:3375–3384.
   PubMed Web of Science ®Google Scholar
• Tsuchida S, Sato K. 1992. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol. 27:337–384.
   PubMed Web of Science ®Google Scholar
• Varga A, Aki-Sener E, Yalcin I, Temiz-Arpaci O, Tekiner-Gulbas B, Cherepnev G, Molnar J. 2005. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr + cells. In Vivo. 19:1087–1092.
   PubMed Web of Science ®Google Scholar
• Waxman DJ. 1990. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy—a review. Cancer Res. 50:6449–6454.
   PubMed Web of Science ®Google Scholar
• Wu CC, Li TK, Farh L, Lin LY, Lin TS, Yu YS, et al. 2011. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science. 333:459–462.
   PubMed Web of Science ®Google Scholar
• Wu G, Robertson DH, Brooks CL III, Vieth M. 2003. Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem. 24:1549–1562.
   PubMed Web of Science ®Google Scholar
• Xiang P, Zhou T, Wang L, Sun C, Hu J, Zhao Y, Yang L. 2012. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation. Molecules. 17:873–883.
   PubMed Web of Science ®Google Scholar
• Yildiz-Oren I, Tekiner-Gulbas B, Yalcin I, Temiz-Arpaci O, Aki-Sener E, Altanlar N. 2004b. Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles. Arch Pharm Med Chem. 337:402–441.
   PubMed Web of Science ®Google Scholar
• Yildiz-Oren I, Yalcin I, Aki-Sener E, Ucarturk N. 2004a. Synthesis and structure–activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem. 39:291–298.
   PubMed Web of Science ®Google Scholar